Home » Topics » BioWorld Science

BioWorld Science
RSS

Rhythm acquires rights to Takeda GOAT inhibitor for Prader-Willi syndrome

April 4, 2018

Taiwan Liposome submits IND for TLC-590

April 3, 2018

FDA issues refusal to file letter for Alkermes' ALKS-5461 NDA

April 3, 2018

Compugen and MedImmune sign cancer immunotherapy license agreement

April 3, 2018

Motif Bio initiates rolling NDA for iclaprim

April 3, 2018

Albert Einstein College of Medicine patents MSC-derived microvesicles

April 3, 2018

Sunovion submits NDA for APL-130277 to treat off episodes associated with Parkinson's disease

April 3, 2018

Novartis targets kinetoplastid proteasome for Chagas disease, leishmaniasis

April 3, 2018

Chinese researchers discover CDK4/6 inhibitors

April 3, 2018

FDA approves Leukine for H-ARS

April 3, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 8, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
ASH 2025: New blood cancer therapies trump chemo, older drugs
BioWorld
Targeted therapies and immunotherapies continue to show better results than chemotherapy in investigator-initiated and company-sponsored cancer trials, and newer...